Renaissance Technologies
MXCT icon

Renaissance Technologies’s MaxCyte MXCT Stock Holding History

Renaissance Technologies’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Sell
1,910,800
-82,400
-4% -$82.1K ﹤0.01% 1867
2026
Q1 		$1.4M Buy
1,993,200
+1,206,300
+153% +$1.13M ﹤0.01% 2092
2025
Q4 		$1.22M Buy
786,900
+36,124
+5% +$57.7K ﹤0.01% 2169
2025
Q3 		$1.19M Buy
750,776
+32,976
+5% +$57.3K ﹤0.01% 2397
2025
Q2 		$1.56M Buy
717,800
+349,900
+95% +$847K ﹤0.01% 2264
2025
Q1 		$1M Buy
367,900
+86,700
+31% +$342K ﹤0.01% 2431
2024
Q4 		$1.17M Buy
281,200
+91,100
+48% +$344K ﹤0.01% 2406
2024
Q3 		$739K Sell
190,100
-20,814
-10% -$87.7K ﹤0.01% 2603
2024
Q2 		$827K Buy
210,914
+48,314
+30% +$208K ﹤0.01% 2428
2024
Q1 		$681K Sell
162,600
-26,500
-14% -$124K ﹤0.01% 2720
2023
Q4 		$889K Sell
189,100
-22,000
-10% -$85.7K ﹤0.01% 2484
2023
Q3 		$659K Buy
211,100
+135,400
+179% +$544K ﹤0.01% 2575
2023
Q2 		$347K Sell
75,700
-25,500
-25% -$117K ﹤0.01% 3069
2023
Q1 		$501K Buy
+101,200
New +$498K ﹤0.01% 2885

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Renaissance Technologies's MXCT Position: Q2 2026 in Review

Renaissance Technologies reduced its MaxCyte (MXCT) stake by 4.1% in Q2 2026, selling an estimated $82.1K and leaving 1,910,800 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1867.

Renaissance Technologies first reported a position in MXCT in Q1 2023 and has held it in 14 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Renaissance Technologies held 1,910,800 shares of MaxCyte worth $2.35M as of Q2 2026.
  • Renaissance Technologies sold 82,400 MaxCyte shares in Q2 2026, an estimated $82.1K.
  • MaxCyte made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1867 holding.
  • Renaissance Technologies first reported a position in MaxCyte in Q1 2023 and has held it in 14 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.